Topics

#VisualAbstract: Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal

09:00 EST 16 Jan 2020 | 2 Minute Medicine

1. In Nepal, the typhoid conjugate vaccine has proven to be very effective in protecting against typhoid fever. 2. The typhoid antibody titers more than quadrupled in the participants that received the typhoid conjugate vaccine. Evidence Rating Level: 1 (Excellent)       Study Rundown: Typhoid fever is a bacterial infection caused by Salmonella that leads to a high fever, weakness, […]
Source: 2 Minute Medicine

Original Article: #VisualAbstract: Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal

NEXT ARTICLE

More From BioPortfolio on "#VisualAbstract: Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal"

Quick Search

Relevant Topics

Typbar-TCV Typhoid Conjugate Vaccine
Typbar-TCV™, world's first clinically proven typhoid conjugate vaccine for infants 6 months & older and Adults. The new vaccine brings hope to millions of adults and infants older than 6 months, by protecting against typhoid fever caused...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...